Skip to main content

Gentamicin Injection Shortage

Last Updated: November 22, 2017
Status: Resolved

Products Affected - Description
    • Gentamicin injection, Pfizer, 60 mg/50 mL, premixed bag, 24 count, NDC 00409-7879-13
Reason for the Shortage
    • Pfizer has discontinued all premixed bags.
    • Baxter did not provide a reason for the shortage.
Available Products
    • Gentamicin injection, Baxter, 100 mg/100 mL, premixed bag, 24 count, NDC 00338-0505-48
    • Gentamicin injection, Baxter, 100 mg/50 mL, premixed bag, 24 count, NDC 00338-0511-41
    • Gentamicin injection, Baxter, 120 mg/100 mL, premixed bag, 24 count, NDC 00338-0507-48
    • Gentamicin injection, Baxter, 60 mg/50 mL, premixed bag, 24 count, NDC 00338-0507-41
    • Gentamicin injection, Baxter, 80 mg/100 mL, premixed bag, 24 count, NDC 00338-0503-48
    • Gentamicin injection, Baxter, 80 mg/50 mL, premixed bag, 24 count, NDC 00338-0509-41
    • Gentamicin injection, Fresenius Kabi, 10 mg/mL, 2 mL vial, 25 count, NDC 63323-0173-02
    • Gentamicin injection, Fresenius Kabi, 40 mg/mL, 2 mL vial, 25 count, NDC 63323-0010-02
    • Gentamicin injection, Fresenius Kabi, 40 mg/mL, 20 mL vial, 25 count, NDC 63323-0010-20
    • Gentamicin injection, Pfizer, 40 mg/mL, 2 mL vial, 25 count, NDC 00409-1207-03

Estimated Resupply Dates

    • All marketed presentations are available.

Updated

Updated November 22, 2017 by Michelle Wheeler, PharmD, Drug Information Specialist. Created May 3, 2016 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer